detumescence
发表于 2025-3-21 17:07:11
书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0830082<br><br> <br><br>书目名称Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0830082<br><br> <br><br>
愉快么
发表于 2025-3-21 21:59:14
http://reply.papertrans.cn/84/8301/830082/830082_2.png
Headstrong
发表于 2025-3-22 00:56:36
Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy978-3-030-56824-5
使人入神
发表于 2025-3-22 08:22:19
http://reply.papertrans.cn/84/8301/830082/830082_4.png
Debate
发表于 2025-3-22 11:08:11
http://reply.papertrans.cn/84/8301/830082/830082_5.png
Expiration
发表于 2025-3-22 14:45:38
http://reply.papertrans.cn/84/8301/830082/830082_6.png
Haphazard
发表于 2025-3-22 20:01:47
Immunopathogenesis of Immune-Related Adverse Events from Cancer Immunotherapyorder to allow the crafting of immunosuppressive/immunomodulatory therapies which will be effective but not compromise the basic antitumoral properties of ICI-based therapies. This chapter reviews current concepts of immunopathogenesis of irAEs and appraises data from in vitro preclinical models and
老人病学
发表于 2025-3-22 23:04:44
Sicca Syndromes condition often develops abruptly and is objectively quite severe. Within the reported cases, we highlight marked clinical heterogeneity with three potential patient subsets: (i) those with . sicca . systemic symptoms, (ii) those with . sicca . systemic symptoms, and (iii) and those with a flare of
NAUT
发表于 2025-3-23 05:00:18
http://reply.papertrans.cn/84/8301/830082/830082_9.png
汇总
发表于 2025-3-23 07:56:22
Book 2021d agents in treating cancer. It provides an overview of cancer immunology,immunotoxicity, and immunotherapies such as ICI, cytokine-based therapy, and CART. It examines the epidemiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of a variety of rheumatic immune-relate